Navigation Links
Detecting esophageal cancer with light
Date:1/4/2011

DURHAM, N.C. A tiny light source and sensors at the end of an endoscope may provide a more accurate way to identify pre-cancerous cells in the lining of the esophagus.

Developed by biomedical engineers at Duke University and successfully tested on patients during a clinical trial at the University of North Carolina at Chapel Hill, the device holds the promise of being a less invasive method for testing patients suspected of having Barrett's esophagus, a change in the lining of the esophagus due to acid reflux. Acid reflux occurs when stomach acid splashes, or refluxes, up into the esophagus.

Long periods of acid reflux can change the cells that line the esophagus, making them appear more like intestinal cells than esophageal cells. These cellular changes can also be a precursor to cancer. As in most cancers, early identification of these pre-cancerous cells often leads to better outcomes for patients. Barrett's esophagus afflicts more than one percent of the U.S. population, with most patients above the age of 50.

Using an endoscope to reach the esophagus via the nose, physicians shine short bursts of this light at locations of suspected disease and sensors capture and analyze the light as it is reflected back. In particular, they are trying to spot characteristic changes within the layer of cells known as the epithelium, which line cavities and surfaces throughout the body.

"By interpreting the way the light scatters after we shine it at a location on the tissue surface, we can the spot the tell-tales signs of cells that are changing from their healthy, normal state to those that may become cancerous," said Neil Terry, a Ph.D. student working in the laboratory of Adam Wax, associate professor of biomedical engineering at Duke's Pratt School of Engineering, who developed the device.

The team published their findings online in the January issue of the journal Gastroenterology.

"Specifically, the nuclei of pre-cancerous cells are larger than typical cell nuclei, and the light scatters back from them in a characteristic manner," Terry continued. "When we compared the findings from our system with an actual review by pathologists, we found they correlated in 86 percent of the samples."

UNC gastroenterologist Nicholas Shaheen, M.D., conducted the preliminary clinical trial of the device on 46 patients with Barrett's esophagus.

"Currently, we take many random tissue samples from areas we where we think abnormal cells may be located," Shaheen said. "This new system may make our biopsies smarter and more targeted. Early detection is crucial, because the cure rate for esophageal cancer that is caught early is quite high, while the cure rate for advanced disease is dismal, with a 15 percent survival rate after five years."

The technology that Wax and his team developed for cancer detection is known as angle-resolved low coherence interferometry (a/LCI). The technique is able to separate the unique patterns of the nucleus from the other parts of the cell and provide representations of its changes in shape in real time.

"This optical approach of sampling allows us to cover more tissue sites in less time and has the potential to significantly improve our ability to spot and monitor these pre-cancerous cells," Wax said. "This type of approach could be used to improve and perhaps one day supplant the physical biopsies currently being used."

Wax pointed out that since approximately 85 percent of all cancers begin within the layers of the epithelium in various parts of the body, he believes that the new system could also work in such cancers as those of the colon, trachea, cervix or bladder.


'/>"/>

Contact: Richard Merritt
richard.merritt@duke.edu
919-660-8414
Duke University
Source:Eurekalert  

Related medicine news :

1. deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer
2. Colorful brains, cooling lasers, disease-detecting lights and more
3. Effective methods for detecting early signs of tremor
4. Sodium MRI gives new insights into detecting osteoarthritis, NYU researchers find
5. Detecting tumors faster
6. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
7. Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery
8. For Most, Chronic Heartburn Not a Big Risk for Esophageal Cancer
9. New clinical trial explores role of vitamin D in preventing esophageal cancer
10. Long-Term Use of Bone Drugs May Be Linked to Esophageal Cancer
11. Drugs used to treat osteoporosis not linked with higher risk of esophageal cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Detecting esophageal cancer with light
(Date:1/23/2017)... ... January 23, 2017 , ... The ... of Anesthesiologists® (ASA®), the Foundation for Anesthesia Education and Research (FAER), the ... and the Cigna Foundation, encourages proposals supporting high quality research using perioperative ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... resources at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist in teaching communities and individuals ... have been developed for use by nutrition educators and influencers within the ...
(Date:1/22/2017)... ... January 22, 2017 , ... Phytocéane invites clients to ... the rest of the world with ZANZIBAR MILKY CREAM. Inspired by the beauty of ... like Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, velvety body ...
(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... Bump eRaiser, recently attended the January ECRM Trade Show in Hilton Head, SC, where ... an international reputation for the quality of its beauty and wellness products. At this ...
(Date:1/21/2017)... SAINT- MALO, FRANCE (PRWEB) , ... January 21, 2017 , ... ... heart of the Indian Ocean, isolated from the rest of the world with ZANZIBAR ... of East Africa, Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 2017 Ahead of today,s trading session, Stock-Callers.com ... have fared at the close: Kite Pharma Inc. (NASDAQ: ... OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ). ... laggards on Friday, January 20 th , 2017, down on the ... on these stocks now at: ...
(Date:1/23/2017)...  ResMed (NYSE : RMD), BMC (Pékin, Chine) et 3B ... qu,ils se sont mis d,accord sur le règlement mondial ... et 3B seront autorisés à vendre leurs produits existants ... ResMed effectuera le paiement de la décision en une ... Floride entre les deux parties. Le règlement n,inclut pas ...
(Date:1/23/2017)... , Jan. 23, 2017 Just two weeks remain until legal ... property, gather in Central London to discuss the ... kind in the market, Parallel Trade 2017 . In ... list of attendees which is available to read in the event ... Some ...
Breaking Medicine Technology: